1. Repository of OAI
Ελληνικά   English  

Browsing by Author Elisaf, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 26 to 45 of 87 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A(2)Saougos, V. G.; Tambaki, A. P.; Kalogirou, M.; Kostapanos, M.; Gazi, I. F.; Wolfert, R. L.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Filippatos, T.; Saougos, V.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of Ezetimibe on Lipoprotein Subfraction Concentrations: The Role of Atorvastatin PretreatmentTsimihodimos, V.; Kalogirou, M.; Lagos, K.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Effect of ezetimibe on lipoprotein subfractions in patients with primary dyslipidemiasKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on LDL subfractions in patients with combined dyslipidemiaTsimihodimos, V.; Irene, G.; Tselepis, A.; Bairaktari, E.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride valuesTsimihodimos, V.; Kostoula, A.; Tzavaras, V.; Kalogirou, M.; Bairaktari, E.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride valuesTsimihodimos, V.; Kostoula, A.; Kakafika, A.; Bairaktari, E.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
The effect of hypolipidaemic agents on lipoprotein-associated phospholipase A2 (Lp-PLA2)Saougos, V.; Filippatos, T.; Kostapanos, M.; Kalogirou, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
The effect of hypolipidaemic drugs on lipoprotein- associated phospholipase A2 (Lp-PLA2) activity and massSaougos, V.; Kostapanos, M.; Kalogirou, M.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetyllhydrolaseTsironis, L. D.; Mitsios, J. V.; Milionis, H. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
The Effect of Nicotinic Acid/Laropiprant Administration on the Lipoprotein-Associated Phospholipase A2 (Lp-Pla2) Activity in Patients with Mixed DyslipidemiaKei, A.; Liberopoulos, E.; Tellis, K.; Rizos, C.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot studyFlorentin, M.; Liberopoulos, E. N.; Filippatos, T. D.; Kostara, C.; Tselepis, A.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of synthetic peptides corresponding to residues 313-332 of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3)Mitsios, J. V.; Tambaki, A. P.; Abatzis, M.; Biris, N.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Soteriadou, K.; Goudevenos, J.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Effects of anithypertensive and hypolipidemic drugs on plasma and lipoprotein-associated PAF-acetylhydrolaseTsimihodimos, V.; Tambaki, A.; Rizos, E.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015-
Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activityTambaki, A. P.; Rizos, E.; Tsimihodimos, V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
The Effects of Ezetimibe and Orlistat, Alone or in Combination, on High Density Lipoprotein (Hdl) Subclasses and Hdl-Associated Enzyme Activities in Overweight and Obese Patients with HyperlipidaemiaNakou, E.; Filippatos, T.; Kiortsis, D.; Derdemezis, C.; Georgoula, M.; Petraki, M.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effects of Rimonabant, as Monotherapy and in Combination With Fenofibrate or Ezetimibe, on Plasma Adipokine Levels: A Pilot StudyFlorentin, M.; Liberopoulos, E. N.; Tellis, C. C.; Derdemezis, C. S.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Estimation of LDL cholesterol based on the Friedewald formula and on apo B levelsBairaktari, E.; Hatzidimou, K.; Tzallas, C.; Vini, M.; Katsaraki, A.; Tselepis, A.; Elisaf, M.; Tsolas, O.24-Nov-2015-
European Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL SubclassesMikhailidis, D. P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V. G.; de Graaf, J.; Marz, W.; Parhofer, K. G.; Rini, G. B.; Spinas, G. A.; Tomkin, G. H.; Tselepis, A. D.; Wierzbicki, A. S.; Winkler, K.; Florentin, M.; Liberopoulos, E.24-Nov-2015-
Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patientsBairaktari, E.; Elisaf, M.; Tzallas, C.; Karabina, S. A.; Tselepis, A. D.; Siamopoulos, K. C.; Tsolas, O.24-Nov-2015-
Showing results 26 to 45 of 87 < previous   next >